共 52 条
[1]
Parker NP(2017)Vocal fold leukoplakia: incidence, management, and prevention Curr Opin Otolaryngol Head Neck Surg 25 464-468
[2]
Panwar A(2013)Management of premalignant lesions of the larynx Expert Rev Anticancer Ther 13 1045-1051
[3]
Lindau R(2010)Consensus statement by otorhinolaryngologists and pathologists on the diagnosis and management of laryngeal dysplasia Clin Otolaryngol 35 170-176
[4]
Wieland A(2017)Recurrence of vocal fold leukoplakia after carbon dioxide laser therapy Eur Arch Otorhinolaryngol 274 1-7
[5]
Mehanna H(2017)Treatment outcome of vocal cord leukoplakia by transoral laser microsurgery Lasers Med Sci 32 19-27
[6]
Chen M(2014)Cancer-related inflammation and treatment effectiveness Lancet Oncol 15 e493-503
[7]
Yang SW(2017)Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer Head Neck 39 219-226
[8]
Diakos CI(2018)The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI Int J Gen Med 11 423-430
[9]
Valero C(2011)Hallmarks of cancer: the next generation Cell 144 646-674
[10]
Phan TT(2017)Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab Lung Cancer 111 176-181